Umban, Angela .

HRN: 27-46-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/11/2025
07/25/2025
IV
4.5 Gram
Now
Sepsis
Remove - Pending Acceptance
07/11/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/11/2025
08/01/2025
IV
2.25 Grams
Q6h
Sepsis
Remove - Pending Acceptance
07/11/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/11/2025
08/08/2025
IV
600 Mg
Q8h
Sepsis
Remove - Pending Acceptance
07/22/2025
CLINDAMYCIN 300MG (CAP)
07/22/2025
07/29/2025
PO
300mg
TID
Sepsis
Remove - Pending Acceptance
07/25/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/25/2025
08/01/2025
IV
600mg
Q6
Sepsis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: